Cover Image

Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer

Triple-negative breast cancer (TNBC) presented as high heterogeneous immunogenicity that lacks useful clinical signatures to risk-stratify immune-benefit subtypes. We hypothesized that molecular-based phenotypic characterization of TNBC tumors and their immunity may overcome these challenges. We enr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cun Liu (Author), Ye Li (Author), Xiaoming Xing (Author), Jing Zhuang (Author), Jigang Wang (Author), Chunyan Wang (Author), Lujun Zhang (Author), Lijuan Liu (Author), Fubin Feng (Author), Huayao Li (Author), Chundi Gao (Author), Yang Yu (Author), Jingyang Liu (Author), Changgang Sun (Author)
Format:	Book
Published:	Elsevier, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
by: Yubao Zhang, et al.
Published: (2021)

The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method
by: Cun Liu, et al.
Published: (2019)

An immunogenomic signature for molecular classification in hepatocellular carcinoma
by: Weiwei Zhuang, et al.
Published: (2021)

Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms
by: Huayao Li, et al.
Published: (2021)

Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
by: Wenfeng Zhang, et al.
Published: (2020)

Deciphering the mechanism of Indirubin and its derivatives in the inhibition of Imatinib resistance using a "drug target prediction-gene microarray analysis-protein network construction" strategy
by: Huayao Li, et al.
Published: (2019)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
by: Xuetong Shen, et al.
Published: (2023)

Development of an immunogenomic landscape for the competing endogenous RNAs network of peri-implantitis
by: Yang Li, et al.
Published: (2020)

Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment
by: Jingyang Liu, et al.
Published: (2022)

Commentary: The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and Its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
by: Yang Yu, et al.
Published: (2022)

Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule
by: Longyun Wang, et al.
Published: (2021)

Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy
by: Ye Li, et al.
Published: (2021)

Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity
by: Xiaowei Xu, et al.
Published: (2022)

An examination of handwritten signatures forged using photosensitive signature stamp
by: Zhen Li, et al.
Published: (2021)

Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning
by: Lijuan Tang, et al.
Published: (2023)

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China
by: Jing Liu, et al.
Published: (2022)

Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma
by: Ke Xu, et al.
Published: (2023)

Identification of prognostic alternative splicing signature in gastric cancer
by: Zhiwu Wang, et al.
Published: (2022)

Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer
by: Sipei Nie, et al.
Published: (2023)

Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic‐associated molecular subtypes and genomic mutations
by: Lijuan Li, et al.
Published: (2023)

Metabolomic landscape of macrophage discloses an anabolic signature of dengue virus infection and antibody-dependent enhancement of viral infection.
by: Li Xu, et al.
Published: (2024)

A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer
by: Renhong Huang, et al.
Published: (2023)

Plasma proteomic signature of neonates in the context of placental histological chorioamnionitis
by: Jing Liu, et al.
Published: (2024)

TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022)

A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor
by: Yujun Guo, et al.
Published: (2024)

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
by: Shuping Zhuang, et al.
Published: (2021)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
by: Yao Y, et al.
Published: (2021)

Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics
by: Dongjiao Wang, et al.
Published: (2022)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
by: Li Liu, et al.
Published: (2023)

A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma
by: KeXin Ma, et al.
Published: (2022)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
by: Yunbao Pan, et al.
Published: (2019)

A Potential Antibody-Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer
by: Wei Zhang, et al.
Published: (2023)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
by: Chi Liu, et al.
Published: (2022)

Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
by: Chong Shen, et al.
Published: (2023)

Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer
by: Wei Hu, et al.
Published: (2021)

Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis
by: Qi Liu, et al.
Published: (2024)

A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
by: Binfeng Liu, et al.
Published: (2022)

Molecular Signatures and Networks of Cardiomyocyte Differentiation in Humans and Mice
by: Yumei Wang, et al.
Published: (2020)

CPDR: An R Package of Recommending Personalized Drugs for Cancer Patients by Reversing the Individual's Disease-Related Signature
by: Ruzhen Chen, et al.
Published: (2022)

Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma
by: Tingting Li, et al.
Published: (2022)